Tributary Capital Management buys $10,381,188 stake in West Pharmaceutical Services (WST)

West Pharmaceutical Services (WST) : Tributary Capital Management scooped up 5,993 additional shares in West Pharmaceutical Services during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 2, 2016. The investment management firm now holds a total of 147,481 shares of West Pharmaceutical Services which is valued at $10,381,188.West Pharmaceutical Services makes up approximately 1.63% of Tributary Capital Management’s portfolio.

West Pharmaceutical Services closed down -0.3 points or -0.42% at $70.39 with 3,23,540 shares getting traded on Friday. Post opening the session at $70.42, the shares hit an intraday low of $69.79 and an intraday high of $70.65 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

Other Hedge Funds, Including , Checchi Capital Advisers added WST to its portfolio by purchasing 7 company shares during the most recent quarter which is valued at $493.Emerald Advisers Incpa boosted its stake in WST in the latest quarter, The investment management firm added 24,850 additional shares and now holds a total of 117,770 shares of West Pharmaceutical Services which is valued at $8,385,224. West Pharmaceutical Services makes up approx 0.41% of Emerald Advisers Incpa’s portfolio.World Asset Management Inc boosted its stake in WST in the latest quarter, The investment management firm added 161 additional shares and now holds a total of 3,538 shares of West Pharmaceutical Services which is valued at $251,906. West Pharmaceutical Services makes up approx 0.01% of World Asset Management Inc’s portfolio. Next Financial Group Inc sold out all of its stake in WST during the most recent quarter. The investment firm sold 106 shares of WST which is valued $7,671.Gw&k Investment Management boosted its stake in WST in the latest quarter, The investment management firm added 26,956 additional shares and now holds a total of 1,180,178 shares of West Pharmaceutical Services which is valued at $85,409,482. West Pharmaceutical Services makes up approx 1.88% of Gw&k Investment Management’s portfolio.

On the company’s financial health, West Pharmaceutical Services reported $0.53 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $0.51. The company had revenue of $362.10 million for the quarter, compared to analysts expectations of $356.32 million. The company’s revenue was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.45 EPS.

Many Wall Street Analysts have commented on West Pharmaceutical Services. West Pharmaceutical Services was Initiated by Wells Fargo to “Outperform” on Mar 22, 2016.

West Pharmaceutical Services Inc. is a manufacturer of components and systems for the packaging and delivery of injectable drugs as well as delivery system components for the pharmaceutical healthcare and consumer products industries. The Company’s products include stoppers and seals for vials prefillable syringe components and systems components for intravenous and blood collection systems safety and administration systems advanced injection systems and contract design and manufacturing services. The Company’s customers include producers of pharmaceuticals biologics medical devices and personal care products. The Company’s reportable segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems).

Leave a Reply

West Pharmaceutical Services - Is it time to Sell?

Top Brokerage Firms are advising their investors on West Pharmaceutical Services. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.